Content about Janssen Pharmaceutica

April 24, 2013
J&J launches diabetes education site for European healthcare professionals

Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.

March 27, 2013
FDA approves Aciphex Sprinkle capsules

The Food and Drug Administration has approved a treatment made by Eisai for gastroesophageal reflux disease in children ages 1 year to 11 years, the drug maker said.

March 18, 2013
Galena buys rights to cancer-pain drug from Orexo

Galena Biopharma has purchased rights to a treatment for breakthrough cancer pain from a Swedish drug maker, Galena said Monday.

December 4, 2012
FDA accepts application for GERD drug in children

The Food and Drug Administration will review an acid-reflux drug made by Eisai for use in children, the drug maker said.

August 23, 2012
AcelRx starts third phase-3 trial of drug for post-operative pain

A drug maker that specializes in pain medications started the third late-stage trial of a drug for treating pain in patients who have undergone certain surgeries.

April 3, 2012
Forest buys rights to Bystolic from J&J

Forest Labs has bought rights to a drug used for high blood pressure that it had marketed with a Johnson & Johnson subsidiary, thus eliminating the need to pay future royalties.

March 14, 2012
Forest files suit over generic versions of hypertension drug

Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

February 8, 2012
Watson, J&J settle lawsuit over generic contraceptive

Subsidiaries of Watson Pharmaceuticals and Johnson & Johnson have settled a lawsuit filed by the latter when Watson attempted to market a generic version of one of its contraceptive drugs.

January 10, 2012
Shire acquires U.S. rights to constipation drug

Shire has acquired U.S. rights to a drug used to treat chronic constipation in women from Johnson & Johnson, the company said Tuesday.

July 29, 2011
Hi-Tech Pharmacal introduces generic Levaquin

A generic version of a popular pneumonia treatment has entered the market from Hi-Tech Pharmacal.

June 28, 2011
Gilead, Tibotec to develop HIV drug

A subsidiary of Johnson & Johnson and Gilead Sciences will collaborate to develop a combination drug for HIV, the two companies said Tuesday.

June 20, 2011
J&J subsidiary recalls one lot of Risperdal, risperidone tablets

Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.

April 11, 2011
Invega approved as schizophrenia treatment for adolescents

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

November 1, 2010
Watson to market, distribute authorized generic ADHD drug

Generic drug maker Watson Pharmaceuticals will distribute an authorized generic version of a drug used...

May 23, 2010
J&J subsidiaries to pay government for alleged Topamax promotion

Two subsidiaries of Johnson & Johnson will pay more than $81 million to the federal...

© 2013 Drug Store News. All Rights Reserved.